相关实验视频
Updated: Jan 13, 2026
05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
1.2K
使用机器学习和网络毒理学在干眼疾病中使用Lifitegrast的计算药监测
Lin Li1, Shixiang Jing1, Xuhua Zhao1
1Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Henan Province Eye Hospital, Henan International Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, Zhengzhou, Henan, China.
NPJ digital medicine
|January 9, 2026
概括
这项研究开发了一种计算框架,用于预测干眼疾病治疗 Lifitegrast 的不良药物事件. 先进的系统准确地识别潜在风险,增强患者安全和个性化医疗.
科学领域:
- 药物监测和计算毒理学
- 精准医学和药物安全 精准医学和药物安全
背景情况:
- 用Lifitegrast治疗干眼病 (DED) 在预测药物不良事件 (ADEs) 方面存在挑战.
- 目前对Lifitegrast ADEs的风险评估方法需要方法上的进步.
研究的目的:
- 建立一个全面的预测框架Lifitegrast使用计算药物监测ADEs.
- 通过先进的方法评估与Lifitegrast相关的治疗风险.
主要方法:
- 使用了FDA不良事件报告系统 (FAERS) 数据库 (2016Q1-2024Q4).
- 开发了一个多层次的ADE预测框架,包括统计学习和网络毒理学.
- 使用神经网络,计算语言学和集体学习来预测风险.
- 创建了一个自动化平台,用于个性化药物安全监测.
主要成果:
- 该计算模型在ADE识别方面取得了高性能 (AUC=0.892,精度=0.847).
- 确定了16个显著的ADE信号,包括插入部位疼痛和痛.
- 网络毒理学确定了ICAM1,MMP9和SRC作为关键的调节基因.
- 神经网络预测了药物向相互作用,通过分子对接验证了强大的结合亲和力.
结论:
- 建立了一个计算增强的Lifitegrast安全评估框架.
- 为药监和精准医学提供了创新的方法解决方案.
- 针对个性化风险分层和实时监控的先进药物安全监测系统.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:16Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304
01:29Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K